Here are the top stories you may have missed.
It's tough to discount the bullish case for biotech and pharmaceutical stocks. For one, millions of retiring baby boomers not only exploring new ways to stave off signs of aging, they are looking to postpone health-related decline and even death. In addition, we're seeing countless mergers and acquisitions. We're also seeing new, innovative treatments for a myriad of issues. And if you're in the right place at the right time, the windfall profits are endless.
Mistakes will be made, even by the pros. However, if you’re aware of potential issues, the better off you are. They Don’t Have a Trading Plan -- Experienced traders get into a trade with a plan. They know exact entry and exit points, the amount of capital to invest in the trade and the maximum loss they are willing to take. Failure to plan can – and oftentimes will – lead to unnecessary loss.
When most folks hear angel investing, they think about the gamble involved with a startup...but we brought together two of the world's most successful angel investors with the goal to help eliminate unnecessary risk altogether. With their unique "1,000x formula" at your disposal, you could secure an opportunity on the ground floor with as little as $50... Click here to see all the details.
Americans' confidence in the economy has become less rosy this month as Gallup's Economic Confidence Index fell to +17 from August's +24 reading, marking the lowest level since the government shutdown ended in January. At the same time, the public is evenly divided over the likelihood of a recession in the next year. The current expectation of a recession is nine points higher than it was in October 2007, just two months before the Great Recession began but slightly below a February 2001 reading, one month before that eight-month-long recession.
There is an incredible new way to become a millionaire from cannabis. It can net you $2,600 or more...week after week...for up to 70 different times over the next 12 months. This unique strategy is less risky and potentially much more profitable than just owning ordinary cannabis stocks. Click here for more.